Document ID: chunk:federal_register_of_legislation:F2024L01389:schedule:1:p24
Version: federal_register_of_legislation:F2024L01389
Segment Type: schedule
Provision Reference: sch 1 (pt 24/66)
Character Range: 66339–69226

the form Tablet 400 mg
omit:
Ibuprofen  Tablet 400 mg  Oral  MEDICHOICE Ibuprofen 400 mg  NB  MP NP MW PDP                        30  0     30
Ibuprofen  Tablet 400 mg  Oral  MEDICHOICE Ibuprofen 400 mg  NB  PDP              P6256 P6282        90  0     30
Ibuprofen  Tablet 400 mg  Oral  MEDICHOICE Ibuprofen 400 mg  NB  MP NP            P6149 P6214 P6283  90  3     30

[147] Schedule 1, Part 1, entry for Imatinib in the form Capsule 400 mg (as mesilate)
insert as first entries:
Imatinib  Capsule 400 mg (as mesilate)  Oral  ARX-IMATINIB  XT  MP  C9203 C9207 C9319 C12525 C12527 C12542 C12543 C13132                       P9203 P9207 P9319 P12525 P12527 P12542 P12543 P13132                       30  2     30

Imatinib  Capsule 400 mg (as mesilate)  Oral  ARX-IMATINIB  XT  MP  C9204 C9206 C9209 C9238 C9240 C9243 C9274 C9276 C9278 C9296 C12536 C12541  P9204 P9206 P9209 P9238 P9240 P9243 P9274 P9276 P9278 P9296 P12536 P12541  30  5     30

[148] Schedule 1, Part 1, entry for Insulin neutral with insulin isophane in the form Injections (human), cartridges, 30 units-70 units per mL, 3 mL, 5
omit:
Insulin neutral with insulin isophane  Injections (human), cartridges, 30 units-70 units per mL, 3 mL, 5  Injection  Mixtard 30/70 Penfill 3 mL  NO  MP NP        5  1     1

[149] Schedule 1, Part 1, entries for Irbesartan in the form Tablet 75 mg
omit:
Irbesartan  Tablet 75 mg  Oral  Karvea  SW  MP NP             30  5     30

Irbesartan  Tablet 75 mg  Oral  Karvea  SW  MP NP     P14238  60  5     30

[150] Schedule 1, Part 1, entry for Isoniazid
insert in the column headed "Circumstances": C15956
[151] Schedule 1, Part 1, entry for Itraconazole in the form Capsule 50 mg
omit from the column headed "Circumstances": C5988 C6005 C6016 C6022 C6035 C6037 C6057 substitute: C15978 C16035 C16073 C16099 C16101 C16102 C16119
[152] Schedule 1, Part 1, entry for Itraconazole in the form Capsule 100 mg
omit:
Itraconazole  Capsule 100 mg  Oral  APO-Itraconazole  TX  MP NP  C5988 C6005 C6016 C6022 C6035 C6037 C6057     60  5     60

[153] Schedule 1, Part 1, entries for Itraconazole in the form Capsule 100 mg
omit from the column headed "Circumstances" (all instances): C5988 C6005 C6016 C6022 C6035 C6037 C6057 substitute (all instances): C15978 C16035 C16073 C16099 C16101 C16102 C16119
[154] Schedule 1, Part 1, entries for Itraconazole in the form Capsule 100 mg
omit from the column headed "Circumstances" (all instances): C5988 C6005 C6016 C6022 C6035 C6037 C6057 substitute (all instances): C15978 C16035 C16073 C16099 C16101 C16102 C16119
[155] Schedule 1, Part 1, entries for Lanreotide in the form Injection 60 mg (as acetate) in single dose pre-filled syringe
(a) omit from the column headed "Circumstances" (all instances): C7509 C7532
(b) insert in numerical order in the column headed "Circumstances" (all instances): C15955 C16024 C16055 C16057

[156] Schedule